Hannokinol is primarily investigated for its potential antimicrobial and antifungal properties. It shows promise in inhibiting the growth of certain pathogenic bacteria and fungi, making it a candidate for development in topical antimicrobial agents. Research also suggests hannokinol may possess anti-inflammatory activity, which could be leveraged in dermatological formulations for treating skin conditions such as eczema or psoriasis. Additionally, its natural origin and bioactivity profile support its exploration in agrochemicals as a bio-based fungicide for crop protection. Studies are ongoing to optimize its stability and delivery in practical formulations.